Vitamins C and E: beneficial effects from a mechanistic perspective. - Abstract - Europe PMC
Prolyl 4-hydroxylases (C-P4H-I, C-P4H-II and C-P4H-III) hydroxylate... | Download Scientific Diagram
Lysyl Hydroxylase - an overview | ScienceDirect Topics
Enzymes-cofactors Dr. Mamoun Ahram. - ppt video online download
Collagen Prolyl Hydroxylation-Dependent Metabolic Perturbation Governs Epigenetic Remodeling and Mesenchymal Transition in Pluripotent and Cancer Cells. - IRBM
Solved Collagen biosynthesis requires an enzyme and a | Chegg.com
Eric Fauman on X: "Hydroxyproline is created by proline hydroxylase in a reaction requiring vitamin C. This is in fact the reason skin and gums start to lose their integrity if you
Ascorbate acts as a reducing agent in the conversion of proline to... | Download Scientific Diagram
Frontiers | Ascorbate as a Co-Factor for Fe- and 2-Oxoglutarate Dependent Dioxygenases: Physiological Activity in Tumor Growth and Progression
Why does prolyl-hydroxylase need Fe2+ and vitamin C as cofactors? - Quora
Enzymatic reaction of HIF-α subunits: HIF prolyl hydroxylases (PHD1-3)... | Download Scientific Diagram
Proline hydroxylation and the maturation of collagen in the ER. (A)... | Download Scientific Diagram
Vitamin C | Basicmedical Key
9.32 Enzymatic Functions | Nutrition Flexbook
Hydroxylation - an overview | ScienceDirect Topics
9.32 Enzymatic Functions | Nutrition Flexbook
Why does prolyl-hydroxylase need Fe2+ and vitamin C as cofactors? - Quora
Vitamin C | Encyclopedia MDPI
Prolin-Hydroxylase - Lexikon der Biologie
L-ascorbic acid: A true substrate for HIF prolyl hydroxylase? - ScienceDirect
Frontiers | Ascorbate as a Co-Factor for Fe- and 2-Oxoglutarate Dependent Dioxygenases: Physiological Activity in Tumor Growth and Progression
Cells | Free Full-Text | Protein Hydroxylation by Hypoxia-Inducible Factor (HIF) Hydroxylases: Unique or Ubiquitous?
Scheme 1. HIF prolyl hydroxylase catalytic cycle accounting for a... | Download Scientific Diagram
Hydroxyproline - Wikipedia
Collagen Prolyl 4-Hydroxylase as a Therapeutic Target. - Abstract - Europe PMC
